GGrantIndex
← Leaderboards

Ned C Sacktor

Johns Hopkins University

Google Scholar ↗PubMed ↗ORCID ↗
$10,719,879
Attributed
$14,269,891
Total exposure
19
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY2005–20
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$14,269,891 · 19

By mechanism

R01$8,778,563 · 4
P30$3,312,823 · 2
P01$1,419,734 · 1
R21$271,513 · 1
R43$248,052 · 1
M01$239,206 · 10

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Hiv Infections”

Research focus

Hiv InfectionsAids Dementia ComplexClinical ResearchNeuroimagingNeurocognitiveNeuropsychological TestsCohortBrainImpaired CognitionParticipantHiv-Associated Neurocognitive DisorderSurrogate MarkersFunctional DisorderHuman SubjectInfectionInflammationClinical TrialsSeveritiesAntiretroviral TherapyClinicPerformanceServicesLaboratoriesBase

Grant awards (56)

Clinical Core$339,101
P30 · FY2020 · MH · contact PI
Mental Health and Cognition in HIV Infection in Rakai Uganda$610,528
R01 · FY2019 · MH · contact PI
Intranasal Insulin Therapy for HIV- Associated Neurocognitive Disorders: Clinical Trial$433,226
P01 · FY2019 · MH · contact PI
Clinical Core$355,992
P30 · FY2019 · MH · contact PI
Intranasal Insulin Therapy for HIV- Associated Neurocognitive Disorders: Clinical Trial$388,256
P01 · FY2018 · MH · contact PI
Clinical Core$364,242
P30 · FY2018 · MH · contact PI
Neurologic Sequelae of HIV Subtype A and D Infection and ART Rakai Uganda$599,170
R01 · FY2017 · MH
Clinical Core$364,243
P30 · FY2017 · MH · contact PI
Intranasal Insulin Therapy for HIV- Associated Neurocognitive Disorders: Clinical Trial$299,777
P01 · FY2017 · MH · contact PI
Neurologic Sequelae of HIV Subtype A and D Infection and ART Rakai Uganda$560,059
R01 · FY2016 · MH
Amyloid Neuroimaging in Older HIV+ Individuals with Cognitive Impairment$529,732
R01 · FY2016 · NS · contact PI
Intranasal Insulin Therapy for HIV- Associated Neurocognitive Disorders: Clinical Trial$261,812
P01 · FY2016 · MH · contact PI
Neurologic Sequelae of HIV Subtype A and D Infection and ART Rakai Uganda$141,145
R01 · FY2016 · MH
Amyloid Neuroimaging in Older HIV+ Individuals with Cognitive Impairment$120,070
R01 · FY2016 · NS · contact PI
Amyloid Neuroimaging in Older HIV+ Individuals with Cognitive Impairment$584,376
R01 · FY2015 · NS · contact PI
Neurologic Sequelae of HIV Subtype A and D Infection and ART Rakai Uganda$568,170
R01 · FY2015 · MH
Clinical Core$388,678
P30 · FY2015 · MH · contact PI
Amyloid Neuroimaging in Older HIV+ Individuals with Cognitive Impairment$126,393
R01 · FY2015 · NS · contact PI
Intranasal Insulin Therapy for HIV- Associated Neurocognitive Disorders: Clinical Trial$36,663
P01 · FY2015 · MH · contact PI
Amyloid Neuroimaging in Older HIV+ Individuals with Cognitive Impairment$590,284
R01 · FY2014 · NS · contact PI
Neurologic Sequelae of HIV Subtype A and D Infection and ART Rakai Uganda$568,045
R01 · FY2014 · MH
Clinical Core$376,972
P30 · FY2014 · MH · contact PI
Neurologic Sequelae of HIV Subtype A and D Infection and ART Rakai Uganda$613,117
R01 · FY2013 · MH
Amyloid Neuroimaging in Older HIV+ Individuals with Cognitive Impairment$578,662
R01 · FY2013 · NS · contact PI
Clinical Core$314,909
P30 · FY2013 · MH · contact PI
Amyloid Neuroimaging in Older HIV+ Individuals with Cognitive Impairment$579,538
R01 · FY2012 · NS · contact PI
Clinical Core$387,166
P30 · FY2012 · MH · contact PI
Clinical Core$17,987
P30 · FY2012 · MH · contact PI
Clinical Core$403,533
P30 · FY2011 · MH · contact PI
A Novel CNS-Penetrable Antiretroviral$248,052
R43 · FY2011 · MH
Oxidative Stress Markers and HIV Dementia$364,017
R01 · FY2009 · MH · contact PI
HIV Dementia and Sensory Neuropathy in Uganda$121,232
R21 · FY2009 · MH · contact PI
Oxidative Stress Markers and HIV Dementia$423,082
R01 · FY2008 · MH · contact PI
HIV Dementia and Sensory Neuropathy in Uganda$150,281
R21 · FY2008 · MH · contact PI
Oxidative Stress Markers and HIV Dementia$426,731
R01 · FY2007 · MH · contact PI
OXIDATIVE STRESS MARKERS AND HIV-ASSOCIATED NEUROLOGICAL DISORDERS$42,684
M01 · FY2007 · RR · contact PI
Oxidative Stress Markers and HIV Dementia$421,543
R01 · FY2006 · MH · contact PI
OXIDATIVE STRESS MARKERS AND HIV-ASSOCIATED NEUROLOGICAL DISORDERS$28,475
M01 · FY2006 · RR · contact PI
ACTG A5090$12,129
M01 · FY2006 · RR · contact PI
Oxidative Stress Markers and HIV Dementia$373,901
R01 · FY2005 · MH
ACTG A5090$84,400
M01 · FY2005 · RR
Clinical Studies of HIV-Associated Neurological Disease$33,293
M01 · FY2004 · RR
ACTG A5090$25,072
M01 · FY2004 · RR
Magnetic Resonance Spectroscopy$13,153
M01 · FY2004 · RR
FUNCTIONAL MRI IN HIV ASSOCIATED PSYCHOMOTOR SLOWING$0
M01 · FY2002 · RR
SAFETY AND EFFICACY TRIAL OF 1592089 IN HIV DEMENTIA$0
M01 · FY2002 · RR
CLINICAL STUDIES OF HIV ASSOCIATED NEUROLGOICAL DISEASES$0
M01 · FY2002 · RR
SAFETY/TOLERABILITY/EFFICACY OF SELEGILINE TRANSDERMAL SYSTEM IN AIDS DEMENTIA$0
M01 · FY2002 · RR
SAFETY/TOLERABILITY/EFFICACY OF SELEGILINE TRANSDERMAL SYSTEM IN AIDS DEMENTIA$0
M01 · FY2001 · RR
SAFETY AND EFFICACY TRIAL OF 1592089 IN HIV DEMENTIA$0
M01 · FY2001 · RR
CLINICAL STUDIES OF HIV ASSOCIATED NEUROLGOICAL DISEASES$0
M01 · FY2001 · RR
FUNCTIONAL MRI IN HIV ASSOCIATED PSYCHOMOTOR SLOWING$0
M01 · FY2001 · RR
FUNCTIONAL MRI IN HIV ASSOCIATED PSYCHOMOTOR SLOWING$0
M01 · FY2000 · RR
CLINICAL STUDIES OF HIV ASSOCIATED NEUROLGOICAL DISEASES$0
M01 · FY2000 · RR
SAFETY/TOLERABILITY/EFFICACY OF SELEGILINE TRANSDERMAL SYSTEM IN AIDS DEMENTIA$0
M01 · FY2000 · RR
SAFETY AND EFFICACY TRIAL OF 1592089 IN HIV DEMENTIA$0
M01 · FY2000 · RR